NCT06625320 · Interventional trial
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Overall registry status Active not recruiting
Phase 3
Conditions PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer
Delaware Valley sites
- Abramson Cancer Center Clinical Research Unit · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory